Identification of genes involved in liver cancer cell growth using an antisense library of phage genomic DNA

Yun Han Lee1, Young Ho Kim, Jong Gu Park

  • 1WelGENE Inc., Daegu, Korea.

Abstract

Insights

Researchers identified genes influencing liver cancer cell growth using a novel large circular (LC-) antisense DNA library. This method screened 1,200 clones, revealing 58 unique genes with growth inhibitory effects, aiding drug discovery.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Liver cancer is a significant global health concern.
  • Identifying genes that drive cancer cell proliferation is crucial for developing effective treatments.
  • Current methods for gene discovery can be time-consuming and lack high-throughput capabilities.

Purpose of the Study:

  • To develop and utilize a novel large circular (LC-) genomic DNA antisense library for identifying genes involved in liver cancer cell growth.
  • To screen this library for molecules that inhibit HepG2 liver cancer cell proliferation.
  • To validate the identified genes through further cell-based assays.

Main Methods:

  • Construction of a subtracted cDNA library using suppression subtractive hybridization (SSH) and unidirectional cloning into an M13 phagemid vector.
  • Preparation of LC-antisense molecules from 1,200 random cDNA clones using M13 bacteriophage life cycle.
  • Transfection of HepG2 cells with LC-antisense molecules and assessment of growth inhibition.

Main Results:

  • Out of 1,200 LC-antisense molecules tested, 153 demonstrated growth inhibitory effects on HepG2 cells.
  • Sequence analysis of these 153 clones led to the identification of 58 unique genes.
  • Further cell-based assays corroborated these findings.

Conclusions:

  • The developed LC-antisense library is a valuable tool for high-throughput screening to discover genes implicated in specific biological functions, such as liver cancer cell growth.
  • This system shows promise as an effective target validation platform for gene-based drug discovery in oncology.